Johnson & JohnsonvsLifeMD

JNJ and LFMD stock compared: price, dividend, valuation and results, from SEC filings.

LFMD

LifeMD, Inc.

$1.57

Value $75M

-7.65%
LFMD's page

Johnson & Johnson (JNJ) has a market value of $642B and LifeMD (LFMD) $75M. Over the last year, with dividends, JNJ moved +36.2% and LFMD -61.6%. Dividend yield: JNJ 1.98%, LFMD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$642B

    LFMD$75M

    JNJ is 8,523 times LFMD

  • Revenue, 12 months

    JNJ$99.3B

    LFMD$188M

    JNJ is 527 times LFMD

  • Net income, 12 months

    JNJ$16.1B

    LFMD-$379.3K

  • Operating margin

    JNJ–

    LFMD-11.4%

  • ROIC

    JNJ12.4%

    LFMD-202.2%

    214.6 points apart

  • P/E

    JNJ39.9

    LFMD–

  • Dividend yield

    JNJ2.0%

    LFMD0.0%

    2.0 points apart

  • 5-year return

    JNJ+88.6%

    LFMD-66.5%

    155.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+88.6%

LFMD-66.5%

10020030020222023202420252026
Returns by period
PeriodJNJWith dividendsLFMDWith dividends
1 year since November 18, 2025+36.2%Price +33.2%-61.6%Price -61.6%
3 years since November 17, 2023+93.7%+24.6% a yearPrice +77.8%-78.2%-39.8% a yearPrice -78.2%
5 years since November 18, 2021+88.6%+13.5% a yearPrice +64.0%-66.5%-19.7% a yearPrice -66.5%
10 years since November 21, 2016+201.9%+11.7% a yearPrice +131.7%+12.1%+1.2% a yearPrice +12.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonLFMDLifeMD

Valuation

JNJLFMD
Valuation
Price$266.37$1.57
Market value$642B$75M
Enterprise value (EV)$669B$53M
P/E39.9–
P/E, 5-year median21.9–
P/B7.9–
EV/EBIT37.7–
Free cash flow yield3.2%–

Results and growth

JNJLFMD
Results and growth
Revenue, 12 months$99.3B$188M
Net income, 12 months$16.1B-$379.3K
Free cash flow, 12 months$20.6B-$11M
Earnings per share, 12 months$6.59-$0.02
Revenue growth, year on year6.1%25.3%
Revenue growth a year, past+2.7%over 5 years+39.1%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJLFMD
Margins and returns on capital
Gross margin67.6%86.7%
Operating margin–-11.4%
Net margin16.2%-0.2%
ROIC12.4%-202.2%
ROE19.7%-4.5%

Balance sheet

JNJLFMD
Balance sheet
Cash$17.2B$22M
Total debt$44.7B$5.9M
Net debt / EBITDA1.1–
Interest cover18.0×–

Dividends and buybacks

JNJLFMD
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%0.4%
Shareholder yield2.9%0.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or LFMD

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or LifeMD?

By market value, Johnson & Johnson ($642B) is about 8,522.8 times LifeMD ($75M), at today's prices.

How did JNJ and LFMD stock do over the last 10 years?

Since November 21, 2016, JNJ's price moved +131.7% and LFMD's +12.1%. With dividends: JNJ +201.9% (+11.7% a year), LFMD +12.1% (+1.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or LFMD?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for LifeMD. Over the last twelve months they paid $5.28 and – per share.

Which has the higher profit margins, Johnson & Johnson or LifeMD?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and -0.2% for LifeMD, and the operating margin – and -11.4%. Revenue was $99.3B and $188M.

Which is the better investment, Johnson & Johnson or LifeMD?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.